A detailed history of Neuberger Berman Group LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 2,893 shares of BIO stock, worth $963,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,893
Previous 1,876 54.21%
Holding current value
$963,108
Previous $512,000 88.87%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $268,457 - $350,498
1,017 Added 54.21%
2,893 $967,000
Q2 2024

Nov 14, 2024

SELL
$268.26 - $339.48 $11,803 - $14,937
-44 Reduced 2.29%
1,876 $512,000
Q2 2024

Aug 13, 2024

SELL
$268.26 - $339.48 $11,803 - $14,937
-44 Reduced 2.29%
1,876 $512,000
Q1 2024

Nov 14, 2024

BUY
$304.11 - $351.99 $23,112 - $26,751
76 Added 4.12%
1,920 $664,000
Q1 2024

May 13, 2024

BUY
$304.11 - $351.99 $583,891 - $675,820
1,920 New
1,920 $664,000
Q4 2023

Nov 14, 2024

SELL
$269.37 - $365.04 $8,619 - $11,681
-32 Reduced 1.71%
1,844 $595,000
Q4 2023

Feb 09, 2024

SELL
$269.37 - $365.04 $15.3 Million - $20.7 Million
-56,721 Reduced 96.85%
1,844 $595,000
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $231,865 - $279,781
662 Added 1.14%
58,565 $21 Million
Q2 2023

Aug 11, 2023

BUY
$359.49 - $486.4 $52,845 - $71,500
147 Added 0.25%
57,903 $22 Million
Q1 2023

May 12, 2023

BUY
$418.69 - $503.0 $8,373 - $10,060
20 Added 0.03%
57,756 $27.7 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $141,035 - $182,860
401 Added 0.7%
57,736 $24.3 Million
Q3 2022

Nov 15, 2022

SELL
$412.59 - $563.26 $178,651 - $243,891
-433 Reduced 0.75%
57,335 $23.9 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $1.43 Million - $1.84 Million
3,075 Added 5.62%
57,768 $28.6 Million
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $30,425 - $42,654
58 Added 0.11%
54,693 $30.7 Million
Q4 2021

Feb 11, 2022

BUY
$708.84 - $794.68 $421,759 - $472,834
595 Added 1.1%
54,635 $41.1 Million
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $16.3 Million - $20.4 Million
-24,713 Reduced 31.38%
54,040 $40.2 Million
Q2 2021

Aug 13, 2021

BUY
$576.64 - $649.04 $8.55 Million - $9.63 Million
14,834 Added 23.21%
78,753 $50.6 Million
Q1 2021

May 13, 2021

BUY
$547.01 - $662.35 $5.85 Million - $7.09 Million
10,698 Added 20.1%
63,919 $36.5 Million
Q4 2020

Feb 10, 2021

SELL
$510.68 - $643.45 $5.72 Million - $7.21 Million
-11,206 Reduced 17.39%
53,221 $31 Million
Q3 2020

Nov 12, 2020

BUY
$454.43 - $535.6 $14,996 - $17,674
33 Added 0.05%
64,427 $33.2 Million
Q2 2020

Aug 13, 2020

BUY
$334.87 - $493.06 $51,235 - $75,438
153 Added 0.24%
64,394 $29.1 Million
Q1 2020

May 14, 2020

SELL
$320.01 - $409.07 $9.6 Million - $12.3 Million
-29,992 Reduced 31.83%
64,241 $22.5 Million
Q4 2019

Feb 12, 2020

SELL
$319.73 - $374.2 $6.54 Million - $7.66 Million
-20,459 Reduced 17.84%
94,233 $34.9 Million
Q3 2019

Nov 13, 2019

BUY
$304.55 - $345.24 $1,522 - $1,726
5 Added 0.0%
114,692 $38.2 Million
Q2 2019

Aug 13, 2019

SELL
$286.93 - $312.59 $6,886 - $7,502
-24 Reduced 0.02%
114,687 $35.9 Million
Q1 2019

May 13, 2019

BUY
$224.3 - $317.41 $45,084 - $63,799
201 Added 0.18%
114,711 $35.1 Million
Q4 2018

Feb 12, 2019

SELL
$220.1 - $309.0 $192,147 - $269,757
-873 Reduced 0.76%
114,510 $26.6 Million
Q3 2018

Nov 13, 2018

SELL
$289.28 - $326.15 $323,125 - $364,309
-1,117 Reduced 0.96%
115,383 $36.1 Million
Q2 2018

Aug 13, 2018

SELL
$244.1 - $303.88 $3.3 Million - $4.1 Million
-13,500 Reduced 10.38%
116,500 $33.6 Million
Q1 2018

May 08, 2018

SELL
$233.97 - $274.11 $297,843 - $348,942
-1,273 Reduced 0.97%
130,000 $32.5 Million
Q4 2017

Feb 14, 2018

SELL
$216.94 - $271.3 $26,032 - $32,556
-120 Reduced 0.09%
131,273 $31.3 Million
Q3 2017

Nov 15, 2017

BUY
$212.27 - $242.28 $27.9 Million - $31.8 Million
131,393
131,393 $29.2 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.